Published with this product (3)
2025Biofabrication
Catherine Reed-McBain, Rithvik V. Turaga, Seth R.T. Zima, Janmesh Patel, Anderson Weber Faletti Cunha, Jason Mixdorf, Lauren E Wehner, Jonathan W. Engle, Reinier Hernandez, Stevens K Rehen, Helena L Borges, and Jose M Ayuso
doi:10.1088/1758-5090/ade1fb2015BMC Neuroscience, 201516:76
Chelsea M. Larabee, Constantin Georgescu, Jonathan D. Wren and Scott M. Plafke
doi:10.1186/s12868-015-0194-y2012PLoS ONE, 7(4): e35541
Frances Y. Cheng, Xi Huang, Anuraag Sarangi, Tatiana Ketova, Michael K. Cooper, Ying Litingtung, Chin Chiang
doi:10.1371/journal.pone.0035541
Description
Human GFAP is a 49,749 dalton protein (432 amino acids) expressed in astrocytes. GFAP is an intermediate filament protein and acts as an intracellular structural component of the cytoskeleton. During embryonic and fetal life, GFAP is also expressed by radial glial cells of the CNS. Various mutations of the GFAP gene in humans produce Alexander's disease, one of the leukodystrophies.
Antibodies to GFAP are therefore very useful as markers of astrocytic cells and neural stem cells. In addition many types of brain tumor, presumably derived from astrocytic cells, heavily express GFAP.


Related products
- Aldehyde Dehydrogenase H1L1 (ALDH1L1)
- ALDH1L1
- Aldolase C
- Beta-Tubulin
- beta-Tubulin
- CD11b/c
- Coronin 1a/p57
- Galectin-3 (LGAS3)
- Galectin-3 Rabbit Polyclonal Antibody
- GAP43
- GAP43 (IgG)
- GFAP
For research use only. Not for diagnostic or clinical use.